Anixa rises on additional US patent for ovarian cancer vaccine tech

Anixa Biosciences

03/10/2023 17:05

** Shares of vaccine and therapy developer Anixa Biosciences
 ANIX.O  rise 1.3% to $3.05
    ** Co says the U.S. Patent and Trademark Office (USPTO) has
issued an additional patent that broadens protection of co's
ovarian cancer vaccine technology
    ** USPTO issued the first patent for co's technology in 2021
    ** Including session's moves, shares down 26.6% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))